| # | Título | Código Publicación | Revista | Indexación Revista | Tipo de Documento | Autores | Año |
|---|---|---|---|---|---|---|---|
| 1 |
Phase Ii, Open Label Study Of Frontline Tusamitamab Ravtansine With Pembrolizumab ± Chemotherapy In Advanced Non Squamous Non Small Cell Lung Cancer: Updated Results From Carmen Lc05 Trial
DOI: 10.1016/J.ANNONC.2024.08.1368 |
WoS: WOS:001326612901613 | Annals Of Oncology |
WOS
|
Meeting Abstract |
|
2024 |
| 2 |
Safety And Efficacy Of Tusamitamab Ravtansine In Combination With Pembrolizumab ± Chemotherapy In Patients With Ceacam5 Positive Nonsquamous Nsclc (Carmen Lc05 Phase Ii Study)
|
WoS: WOS:000995007600014 | Journal Of Thoracic Oncology |
WOS
|
Meeting Abstract |
|
2023 |